
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
孙福荣, 郭杨, 马勇, 等. 温肾通络止痛颗粒对去卵巢大鼠骨密度及骨代谢的影响[J]. 中国实验方剂学杂志, 2012,18(21):275-277.
SUN Fu-rong, GUO Yang, MA Yoing, et al. Effect of Wenshen Tongluo Zhitong Granule on Bone Mineral Density and Bone Metabolism in Ovariectomized Rats[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(21): 275-277.
孙福荣, 郭杨, 马勇, 等. 温肾通络止痛颗粒对去卵巢大鼠骨密度及骨代谢的影响[J]. 中国实验方剂学杂志, 2012,18(21):275-277. DOI:
SUN Fu-rong, GUO Yang, MA Yoing, et al. Effect of Wenshen Tongluo Zhitong Granule on Bone Mineral Density and Bone Metabolism in Ovariectomized Rats[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(21): 275-277. DOI:
目的: 观察温肾通络止痛颗粒对去卵巢大鼠骨密度及骨代谢的影响
探究其防治骨质疏松症的机制。 方法: 将90只雌性大鼠随机分成空白对照组
模型组
温肾通络止痛颗粒低、中、高剂量组(按生药量计为4
8
16 g ·kg-1)及尼尔雌醇组(1 mg ·kg-1)共6组
采用卵巢切除的方法制成骨质疏松动物模型
ig给药3个月后进行骨密度(BMD)、降钙素(CT)、骨钙素(BGP)及雌二醇(E2)等骨代谢指标的检测。 结果: 对照组、模型组、尼尔雌醇组、温肾通络止痛颗粒低、中、高剂量组BMD分别是(0.231 8±0.003 6)
(0.198 8±0.003 9)
(0.219 9±0.002 4)
(0.201 1±0.000 9)
(0.202 3±0.002 7)
(0.220 2±0.002 1)g ·cm-2;CT含量分别为(74.61±10.54)
(48.33±13.72)
(71.72±14.83)
(56.76±12.58)
(68.39±13.74)
(75.29±15.63)ng ·L-1;E2含量分别为(88.61±17.54)
(28.45±11.39)
(71.71±8.69)
(68.11±12.63)
(70.93±10.42)
(75.21±9.37) ng ·L-1。模型组及各治疗组BGP含量与空白对照组比较无显著差异。温肾通络止痛颗粒低、中、高剂量组股骨BMD
CT
E2含量升高
与模型组相比差异具有显著意义(P<0.05)
以高剂量组效果最明显(P<0.01)。 结论: 温肾通络止痛颗粒能够明显提高去卵巢大鼠骨密度值
改善其骨代谢状况
从而起到抗骨质疏松作用。
Objective: To investigate the effect of Wenshen Tongluo Zhitong granule on osteoporosis in rat ovariectomized model
to explore its mechanism. Method: Ninety female rats were randomly divided into control group
model group
low-dose
medium-dose
high-dose Wenshen Tongluo Zhitong granule groups and nyestrid(CEE3) group. Animal models of osteoporosis was induced with the ovariectomized method
and intragastric administration was performed.The bone mineral density(BMD)
calcitonin(CT)
bone Gla protein (BGP) and estradiol(E2) after 3 months were measured. Result: The BMD content in the control group
model group
CEE3 group
low-dose
medium-dose
high-dose of Wenshen Tongluo Zhitong granule group was(0.231 8±0.003 6)
(0.198 8±0.003 9)
(0.219 9±0.002 4)
(0.201 1±0.000 9)
(0.202 3±0.002 7)
(0.220 2±0.002 1)g·cm-2
the CT content is (74.61±10.54)
(48.33±13.72)
(71.72±14.83)
(56.76±12.58)
(68.39±13.74)
(75.29±15.63) ng·L-1
the BGP content is (5.95±1.20)
(5.46±1.34)
(6.27±1.21)
(6.08±1.24)
(6.12±1.47)
(6.15±1.19) μg·L-1
the E2 content is (88.61±17.54)
(28.45±11.39)
(71.71±8.69)
(68.11±12.63)
(70.93±10.42)
(75.21±9.37) ng·L-1. The BGP content in ovariectomized rats had no significant change in the model group
treatment groups and CEE3 group compared to the control group. The BMD and CT content in treatment groups significantly increased compared with the model group
and the high dose group improved most significantly (P<0.01). The E2 content in treatment groups significantly increased compared with the model group(P<0.01). Conclusion: Wenshen Tongluo Zhitong granule can significantly increases bone mineral density and improve bone metabolism in ovariectomized rats
which plays the role of anti-osteoporosis.
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621